Upcoming Dividend • Jul 16
Upcoming dividend of €0.041 per share Eligible shareholders must have bought the stock before 23 July 2026. Payment date: 27 July 2026. Payout ratio is on the higher end at 89%, and the cash payout ratio is above 100%. Trailing yield: 7.8%. Within top quartile of Spanish dividend payers (5.2%). Higher than average of industry peers (3.3%). Announcement • Apr 30
Naturhouse Health, S.A., Annual General Meeting, May 29, 2026 Naturhouse Health, S.A., Annual General Meeting, May 29, 2026. Upcoming Dividend • Apr 09
Upcoming dividend of €0.041 per share Eligible shareholders must have bought the stock before 16 April 2026. Payment date: 20 April 2026. Payout ratio is on the higher end at 89%, and the cash payout ratio is above 100%. Trailing yield: 7.7%. Within top quartile of Spanish dividend payers (5.0%). Higher than average of industry peers (3.4%). Reported Earnings • Mar 26
Full year 2025 earnings released: EPS: €0.17 (vs €0.17 in FY 2024) Full year 2025 results: EPS: €0.17 (up from €0.17 in FY 2024). Revenue: €47.6m (down 3.6% from FY 2024). Net income: €10.1m (up 2.3% from FY 2024). Profit margin: 21% (up from 20% in FY 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 12% per year, which means it is well ahead of earnings. Declared Dividend • Mar 25
Dividend of €0.041 announced Shareholders will receive a dividend of €0.041. Ex-date: 16th April 2026 Payment date: 20th April 2026 Dividend yield will be 11%, which is higher than the industry average of 2.5%. Sustainability & Growth Dividend is not covered by earnings (117% earnings payout ratio) nor is it covered by cash flows (110% cash payout ratio). The dividend has increased by an average of 7.2% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to grow by 30% to bring the payout ratio under control, which is more than the 3.4% EPS growth achieved over the last 5 years. New Risk • Feb 06
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Spanish stocks, typically moving 4.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 117% Cash payout ratio: 110% Earnings are forecast to decline by an average of 4.6% per year for the foreseeable future. Minor Risk Share price has been volatile over the past 3 months (4.4% average weekly change). Buy Or Sell Opportunity • Feb 06
Now 21% overvalued after recent price rise Over the last 90 days, the stock has risen 28% to €2.57. The fair value is estimated to be €2.12, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 4.1% over the last 3 years. Earnings per share has declined by 2.6%. Revenue is forecast to grow by 0.09% in 2 years. Earnings are forecast to decline by 11% in the next 2 years. Upcoming Dividend • Jan 23
Upcoming dividend of €0.081 per share Eligible shareholders must have bought the stock before 30 January 2026. Payment date: 03 February 2026. The company is paying out more than 100% of its earnings and cash flow. Trailing yield: 8.0%. Within top quartile of Spanish dividend payers (5.3%). Higher than average of industry peers (3.2%). Buy Or Sell Opportunity • Dec 24
Now 20% overvalued after recent price rise Over the last 90 days, the stock has risen 13% to €2.24. The fair value is estimated to be €1.86, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 4.1% over the last 3 years. Earnings per share has declined by 2.6%. Revenue is forecast to grow by 0.09% in 2 years. Earnings are forecast to decline by 11% in the next 2 years. Buy Or Sell Opportunity • Oct 20
Now 20% overvalued after recent price rise Over the last 90 days, the stock has risen 25% to €2.30. The fair value is estimated to be €1.91, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 4.1% over the last 3 years. Earnings per share has declined by 2.6%. Revenue is forecast to grow by 0.09% in 2 years. Earnings are forecast to decline by 11% in the next 2 years. Upcoming Dividend • Oct 15
Upcoming dividend of €0.081 per share Eligible shareholders must have bought the stock before 22 October 2025. Payment date: 24 October 2025. Payout ratio is a comfortable 59% but the company is paying out more than the cash it is generating. Trailing yield: 8.9%. Within top quartile of Spanish dividend payers (5.3%). Higher than average of industry peers (3.5%). Reported Earnings • Oct 05
First half 2025 earnings released: EPS: €0.10 (vs €0.097 in 1H 2024) First half 2025 results: EPS: €0.10 (up from €0.097 in 1H 2024). Revenue: €26.4m (down 5.8% from 1H 2024). Net income: €6.19m (up 6.2% from 1H 2024). Profit margin: 24% (up from 21% in 1H 2024). The increase in margin was driven by lower expenses. Revenue is forecast to stay flat during the next 3 years compared to a 5.6% growth forecast for the Specialty Retail industry in Europe. Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 12% per year, which means it is well ahead of earnings. Buy Or Sell Opportunity • Oct 03
Now 20% overvalued after recent price rise Over the last 90 days, the stock has risen 22% to €2.26. The fair value is estimated to be €1.88, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 4.1% over the last 3 years. Earnings per share has declined by 3.1%. Revenue is forecast to grow by 0.09% in 2 years. Earnings are forecast to decline by 11% in the next 2 years. New Risk • Jun 19
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 3.1% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 3.1% per year for the foreseeable future. Minor Risk Dividend is not well covered by cash flows (107% cash payout ratio). Announcement • May 22
Naturhouse Health, S.A., Annual General Meeting, Jun 27, 2025 Naturhouse Health, S.A., Annual General Meeting, Jun 27, 2025. Reported Earnings • Apr 03
Full year 2024 earnings: EPS and revenues miss analyst expectations Full year 2024 results: EPS: €0.16 (down from €0.19 in FY 2023). Revenue: €49.4m (down 1.9% from FY 2023). Net income: €9.86m (down 13% from FY 2023). Profit margin: 20% (down from 22% in FY 2023). The decrease in margin was primarily driven by lower revenue. Revenue missed analyst estimates by 1.2%. Earnings per share (EPS) also missed analyst estimates by 5.9%. Revenue is forecast to grow 2.9% p.a. on average during the next 2 years, compared to a 5.9% growth forecast for the Specialty Retail industry in Europe. Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings. New Risk • Jan 12
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Reported Earnings • Oct 02
First half 2024 earnings released: EPS: €0.097 (vs €0.12 in 1H 2023) First half 2024 results: EPS: €0.097 (down from €0.12 in 1H 2023). Revenue: €28.0m (down 1.8% from 1H 2023). Net income: €5.83m (down 21% from 1H 2023). Profit margin: 21% (down from 26% in 1H 2023). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 2.0% p.a. on average during the next 3 years, compared to a 6.6% growth forecast for the Specialty Retail industry in Europe. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings. New Risk • Oct 01
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (5.6% average weekly change). Earnings are forecast to decline by an average of 2.0% per year for the foreseeable future. Minor Risks Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Valuation Update With 7 Day Price Move • Sep 04
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to €1.81, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 12x in the Specialty Retail industry in Europe. Total returns to shareholders of 36% over the past three years. Upcoming Dividend • Aug 22
Upcoming dividend of €0.081 per share Eligible shareholders must have bought the stock before 29 August 2024. Payment date: 02 September 2024. Payout ratio is a comfortable 41% and this is well supported by cash flows. Trailing yield: 5.2%. Lower than top quartile of Spanish dividend payers (5.5%). Higher than average of industry peers (3.4%). Buy Or Sell Opportunity • Aug 11
Now 20% overvalued after recent price rise Over the last 90 days, the stock has risen 10% to €1.83. The fair value is estimated to be €1.52, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 4.2% over the last 3 years. Earnings per share has declined by 5.6%. For the next 3 years, revenue is forecast to grow by 1.4% per annum. Earnings are forecast to decline by 2.0% per annum over the same time period. Buy Or Sell Opportunity • Jun 06
Now 21% overvalued after recent price rise Over the last 90 days, the stock has risen 6.7% to €1.68. The fair value is estimated to be €1.38, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 4.2% over the last 3 years. Earnings per share has declined by 5.6%. For the next 3 years, revenue is forecast to grow by 1.4% per annum. Earnings are forecast to decline by 2.0% per annum over the same time period. Buy Or Sell Opportunity • May 15
Now 20% overvalued after recent price rise Over the last 90 days, the stock has risen 7.4% to €1.67. The fair value is estimated to be €1.39, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 4.2% over the last 3 years. Earnings per share has declined by 5.6%. For the next 3 years, revenue is forecast to grow by 1.4% per annum. Earnings are forecast to decline by 2.0% per annum over the same time period. Upcoming Dividend • Apr 11
Upcoming dividend of €0.041 per share Eligible shareholders must have bought the stock before 18 April 2024. Payment date: 22 April 2024. Payout ratio is a comfortable 41% and this is well supported by cash flows. Trailing yield: 5.9%. Within top quartile of Spanish dividend payers (5.9%). Higher than average of industry peers (3.5%). Buy Or Sell Opportunity • Apr 04
Now 20% overvalued Over the last 90 days, the stock has fallen 2.9% to €1.68. The fair value is estimated to be €1.39, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 4.2% over the last 3 years. Earnings per share has declined by 5.6%. For the next 3 years, revenue is forecast to grow by 1.4% per annum. Earnings are forecast to decline by 2.0% per annum over the same time period. Reported Earnings • Mar 20
Full year 2023 earnings: EPS and revenues exceed analyst expectations Full year 2023 results: EPS: €0.19 (up from €0.16 in FY 2022). Revenue: €50.4m (down 3.8% from FY 2022). Net income: €11.3m (up 17% from FY 2022). Profit margin: 22% (up from 18% in FY 2022). The increase in margin was driven by lower expenses. Revenue exceeded analyst estimates by 11%. Earnings per share (EPS) also surpassed analyst estimates by 27%. Revenue is forecast to grow 1.4% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Specialty Retail industry in Europe. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has fallen by 4% per year. New Risk • Oct 31
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: €94.1m (US$99.9m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 6.6% per year for the foreseeable future. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (€94.1m market cap, or US$99.9m). Buying Opportunity • Sep 25
Now 20% undervalued The stock has been flat over the last 90 days. The fair value is estimated to be €2.16, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 12% over the last 3 years, while earnings per share has been flat. For the next 3 years, revenue is forecast to decline by 3.1% per annum. Earnings is also forecast to decline by 0.3% per annum over the same time period. New Risk • Sep 17
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 93% Cash payout ratio: 98% Earnings are forecast to decline by an average of 0.3% per year for the foreseeable future. High level of non-cash earnings (24% accrual ratio). Minor Risk Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Upcoming Dividend • Sep 14
Upcoming dividend of €0.041 per share at 5.7% yield Eligible shareholders must have bought the stock before 21 September 2023. Payment date: 25 September 2023. Payout ratio is on the higher end at 93%, and the cash payout ratio is above 100%. Trailing yield: 5.7%. Lower than top quartile of Spanish dividend payers (6.1%). Higher than average of industry peers (3.4%). New Risk • Sep 01
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 93% Cash payout ratio: 98% Earnings are forecast to decline by an average of 0.3% per year for the foreseeable future. High level of non-cash earnings (24% accrual ratio). Minor Risk Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Buying Opportunity • Aug 10
Now 20% undervalued after recent price drop Over the last 90 days, the stock is down 5.4%. The fair value is estimated to be €2.09, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 12% over the last 3 years, while earnings per share has been flat. For the next 3 years, revenue is forecast to decline by 3.1% per annum. Earnings is also forecast to decline by 0.3% per annum over the same time period. Upcoming Dividend • Jun 21
Upcoming dividend of €0.041 per share at 5.7% yield Eligible shareholders must have bought the stock before 28 June 2023. Payment date: 30 June 2023. Payout ratio is on the higher end at 93%, and the cash payout ratio is above 100%. Trailing yield: 5.7%. Lower than top quartile of Spanish dividend payers (5.8%). Higher than average of industry peers (3.6%). Buying Opportunity • Mar 07
Now 21% undervalued Over the last 90 days, the stock is up 13%. The fair value is estimated to be €2.32, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 12% over the last 3 years, while earnings per share has been flat. Reported Earnings • Mar 04
Full year 2022 earnings released: EPS: €0.16 (vs €0.22 in FY 2021) Full year 2022 results: EPS: €0.16 (down from €0.22 in FY 2021). Revenue: €52.6m (down 8.7% from FY 2021). Net income: €9.63m (down 28% from FY 2021). Profit margin: 18% (down from 23% in FY 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has remained flat whereas the company’s share price has fallen by 3% per year. Buying Opportunity • Feb 13
Now 20% undervalued Over the last 90 days, the stock is up 23%. The fair value is estimated to be €2.53, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 16% over the last 3 years. Earnings per share has grown by 2.8%. Revenue is forecast to grow by 11% in 2 years. Earnings is forecast to grow by 13% in the next 2 years. Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 1 experienced director. 6 highly experienced directors. 3 independent directors (4 non-independent directors). Independent Director Ignacio Bayon Marine was the last independent director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Oct 05
Investor sentiment deteriorated over the past week After last week's 16% share price decline to €1.51, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 10x in the Specialty Retail industry in Europe. Total loss to shareholders of 3.7% over the past three years. Reported Earnings • Sep 20
First half 2022 earnings released: EPS: €0.11 (vs €0.081 in 1H 2021) First half 2022 results: EPS: €0.11. Revenue: €30.3m (down 5.5% from 1H 2021). Net income: €6.62m (down 21% from 1H 2021). Profit margin: 22% (down from 26% in 1H 2021). Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. 3 independent directors (4 non-independent directors). Independent Director Ignacio Bayon Marine was the last independent director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Upcoming Dividend • Mar 10
Upcoming dividend of €0.16 per share Eligible shareholders must have bought the stock before 17 March 2022. Payment date: 21 March 2022. Payout ratio is a comfortable 20% and this is well supported by cash flows. Trailing yield: 3.0%. Lower than top quartile of Spanish dividend payers (5.5%). In line with average of industry peers (3.2%). Reported Earnings • Mar 04
Full year 2021 earnings: EPS and revenues miss analyst expectations Full year 2021 results: EPS: €0.22 (up from €0.16 in FY 2020). Revenue: €57.6m (up 4.6% from FY 2020). Net income: €18.2m (up 95% from FY 2020). Profit margin: 32% (up from 17% in FY 2020). The increase in margin was primarily driven by lower expenses. Revenue missed analyst estimates by 100%. Earnings per share (EPS) also missed analyst estimates by 100%. Over the next year, revenue is forecast to grow 13%, compared to a 16% growth forecast for the retail industry in Spain. Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has fallen by 7% per year. Reported Earnings • Sep 22
Second quarter 2021 earnings released: EPS €0.081 (vs €0.02 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: €17.5m (up 52% from 2Q 2020). Net income: €4.83m (up 309% from 2Q 2020). Profit margin: 28% (up from 10% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 14% per year whereas the company’s share price has fallen by 15% per year. Upcoming Dividend • Aug 27
Upcoming dividend of €0.049 per share Eligible shareholders must have bought the stock before 03 September 2021. Payment date: 07 September 2021. Trailing yield: 3.5%. Lower than top quartile of Spanish dividend payers (4.9%). Higher than average of industry peers (2.3%). Reported Earnings • Mar 05
Full year 2020 earnings released: EPS €0.16 (vs €0.22 in FY 2019) The company reported a poor full year result with weaker earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: €55.1m (down 33% from FY 2019). Net income: €9.38m (down 29% from FY 2019). Profit margin: 17% (in line with FY 2019). Over the last 3 years on average, earnings per share has fallen by 27% per year whereas the company’s share price has fallen by 23% per year. Analyst Estimate Surprise Post Earnings • Mar 05
Revenue misses expectations Revenue missed analyst estimates by 18%. Over the next year, revenue is forecast to grow 23%, compared to a 8.1% growth forecast for the Specialty Retail industry in Spain. Valuation Update With 7 Day Price Move • Jan 05
Investor sentiment improved over the past week After last week's 18% share price gain to €1.69, the stock is trading at a trailing P/E ratio of 11.2x, up from the previous P/E ratio of 9.5x. This compares to an average P/E of 18x in the Specialty Retail industry in Europe. Total return to shareholders over the past three years is a loss of 52%. Is New 90 Day High Low • Jan 05
New 90-day high: €1.69 The company is up 33% from its price of €1.27 on 07 October 2020. The Spanish market is up 15% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Specialty Retail industry, which is up 6.0% over the same period. Reported Earnings • Dec 19
Third quarter 2020 earnings released: EPS €0.064 The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2020 results: Revenue: €14.9m (down 20% from 3Q 2019). Net income: €3.84m (up 11% from 3Q 2019). Profit margin: 26% (up from 19% in 3Q 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 29% per year whereas the company’s share price has fallen by 30% per year. Valuation Update With 7 Day Price Move • Nov 26
Market bids up stock over the past week After last week's 18% share price gain to €1.62, the stock is trading at a trailing P/E ratio of 11.2x, up from the previous P/E ratio of 9.5x. This compares to an average P/E of 18x in the Specialty Retail industry in Europe. Total return to shareholders over the past three years is a loss of 52%. Is New 90 Day High Low • Nov 20
New 90-day high: €1.47 The company is up 2.0% from its price of €1.44 on 21 August 2020. The Spanish market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Specialty Retail industry, which is up 17% over the same period. Valuation Update With 7 Day Price Move • Nov 11
Market bids up stock over the past week After last week's 17% share price gain to €1.41, the stock is trading at a trailing P/E ratio of 9.7x, up from the previous P/E ratio of 8.3x. This compares to an average P/E of 18x in the Specialty Retail industry in Europe. Total return to shareholders over the past three years is a loss of 59%. Is New 90 Day High Low • Oct 30
New 90-day low: €1.17 The company is down 23% from its price of €1.51 on 31 July 2020. The Spanish market is down 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Specialty Retail industry, which is up 2.0% over the same period. Reported Earnings • Sep 29
First half earnings released Over the last 12 months the company has reported total profits of €8.64m, down 32% from the prior year. Total revenue was €63.8m over the last 12 months, down 23% from the prior year.